Esbelta Chupapanza: FDA found undeclared phenolphthalein

The FDA advises consumers not to purchase or use Esbelta Chupapanza Flat Belly, a product promoted for weight loss on websites including elegantfigure.com and possibly in some retail stores. FDA laboratory analysis confirmed phenolphthalein that was not listed on the label. That is a specific finding about the product FDA tested—not a guess based on its name or marketing. [1]

What FDA found in Esbelta Chupapanza

The FDA notice is dated August 18, 2026. It says phenolphthalein is not an active ingredient in any FDA-approved US drug and that studies suggest it may increase cancer risk. The National Toxicology Program classifies phenolphthalein as reasonably anticipated to be a human carcinogen based on animal studies; it also says available human cancer data are inadequate. [1][2]

Why phenolphthalein is a serious concern

The key issue is not that this notice proves a person will get cancer from taking the product. It does not. The problem is that a substance absent from the label was found in a weight-loss product, while the amount and exposure are not stated. A buyer cannot use the label to judge what is in the product or make an informed decision. FDA also warns that contaminated weight-loss products can pose serious health risks and are not guaranteed to work. [1][3]

What this evidence does and does not show

FDA does not publish the tested lot number, the concentration of phenolphthalein, total sales, or a complete list of sellers in this notice. It does not establish that every package is identical, what a particular seller knew, or that the product safely causes weight loss. We found no verified evidence here for a phone upsell, a high-priced “course,” or deliberate deception by a named seller, so we do not claim those things. These translations report a US FDA notice; they do not establish sales or regulatory status elsewhere. [1]

What US buyers should do

• If you have this product, follow the FDA advice: do not buy or use it. Keep the package and label so a healthcare professional or pharmacist can identify it. [1]
• If you have taken it, contact a healthcare professional or pharmacist and show them the FDA notice, especially if you feel unwell. Do not stop prescribed medicines on your own. [1]
• For urgent or severe symptoms in the United States, call 911. Report a suspected reaction to FDA MedWatch through the reporting link on the FDA notice. [1]

Our assessment

We do not recommend Esbelta Chupapanza Flat Belly. FDA laboratory testing found undeclared phenolphthalein in a product promoted for weight loss, and the agency explicitly advises consumers not to purchase or use it. The cancer-hazard classification is based on animal evidence; available human evidence is inadequate, so we do not present cancer as a proven outcome in people. The finding applies to the tested product, not automatically to every similarly named item or seller.